PATENT CLAIM ANALYSIS

Application Number: 16246380
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "259000"]

Abstract:
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R 1 , R 2 , R 3 , R 4 , R 5 , and n are as defined herein.

Claim (Index 10):
The compound according to  claim 1 , wherein:\n R 1  is independently H or F; R 2  is H; R 3  is independently a 5-membered heteroaryl comprising carbon atoms and 1-4 heteroatoms selected from N, NR a , O, and S(O) p ; wherein said heteroaryl is substituted with 0-3 R 3A ; and R a  is independently selected from: H, C 1 -C 4  alkyl substituted with 0-1 R b , \u2014C(\u2550O)H, \u2014C(\u2550O)(C 1 -C 4  alkyl), \u2014CO 2 (C 1 -C 4  alkyl), C 3 -C 6  cycloalkyl, and benzyl.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 99.0
- Lexical Diversity: 1.27907
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14977273', '15538348', '16311575', '16311621', '16012468']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7743172744196584
- 35 USC 102 Novelty (BERT): 0.6028821147002715
- Combined Prediction Score: 0.7571737584477197
- Mean Citation Score: 448.49072400000006
- Max Citation Score: 509.5315
- Similarity Product: 488.7002909379005

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test